OpenVSafe by OpenVAERS
Search V-safe

57S-14024-88078

2 vaccinations 3 coded responses 4 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
193 / PA
Registered
2021-04-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-23
    Registered in v-safe
  3. 2021-04-23
    Survey response — day 14, dose 1
    MedDRA: Dyspnoea, Eye irritation, Headache, Inflammation, Musculoskeletal chest pain, Pain, Self-medication — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Still experiencing shortness of breath and respiratory problems and pain in chest wall from inflammation. Horrendous headaches that last for 20 hours out of 24 hours. Not relieved with OTC Tylenol, Advil, or aspirin. Terrible pain and burning in eyes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-27
    Survey response — day 21, dose 1
    MedDRA: Fatigue, Headache, Respiratory disorder, Vision blurred — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Continuing to have respiratory issues and required another prednisone prescription. Extreme fatigue and blurred vision extreme Headaches still persist.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-27
    Report sent to call center — day 21, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-05-05
    Health check-in — day 28, dose 1
    Feeling: Fair
    Adult check-in
  7. 2021-05-17
    Dose 2 — Pfizer-BioNTech
  8. 2021-07-06
    Survey response — 3 months, dose 1
    MedDRA: Alopecia, Office visit, Respiratory disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Symptoms: Respiratory problems and massive hair loss. · Healthcare visit (other): Primary care physician and a specialist
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-07-06
    Report sent to call center — 3 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  10. 2021-07-08
  11. 2021-08-06
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-04-05Pfizer-BioNTech
22021-05-17Pfizer-BioNTech No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-23

Symptoms: Still experiencing shortness of breath and respiratory problems and pain in chest wall from inflammation. Horrendous headaches that last for 20 hours out of 24 hours. Not relieved with OTC Tylenol, Advil, or aspirin. Terrible pain and burning in eyes cut off by CDC

Release 8 — day 21, dose 1

2021-04-27

Symptoms: Continuing to have respiratory issues and required another prednisone prescription. Extreme fatigue and blurred vision extreme Headaches still persist.

Release 9 — 3 months, dose 1

2021-07-06

Symptoms: Respiratory problems and massive hair loss.
Healthcare visit (other): Primary care physician and a specialist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDAlopecia ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDEye irritation ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDInflammation ✓ ✓ ✓
SDMusculoskeletal chest pain ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDRespiratory disorder ✓ ✓ ✓
SDSelf-medication ✓ ✓ ✓
SDVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release